Acceleration of autologous invivo recellularization of decellularized aortic conduits by fibronectin surface coating

Biomaterials

Volumn 34, Issue 25, 2013, Pages 6015-6026

  Assmann, Alexander ^a   Delfs, Christofer ^a   Munakata, Hiroshi ^a   Schiffer, Franziska ^a   Horstkötter, Kim ^a   Huynh, Khon ^a   Barth, Mareike ^a   Stoldt, Volker R ^a   Kamiya, Hiroyuki ^a   Boeken, Udo ^a   Lichtenberg, Artur ^a   Akhyari, Payam ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Biocompatibility; Endothelialisation; Extracellular matrix; Fibronectin; Heart valve; Vascular grafts

Indexed keywords

ENDOTHELIALISATION; EXTRACELLULAR MATRICES; FIBRONECTIN; HEART VALVES; VASCULAR GRAFTS;

BIOCOMPATIBILITY; BIOMINERALIZATION; BLOOD VESSELS; CELL ADHESION; ENZYME INHIBITION; FLUORESCENCE; GRAFTS; POLYMERASE CHAIN REACTION; PROTEINS;

COATINGS;

ALPHA SMOOTH MUSCLE ACTIN; CD3 ANTIGEN; CD68 ANTIGEN; DESMIN; DETERGENT; FIBRONECTIN; MATRIX METALLOPROTEINASE;

ACCELERATION; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA INTIMA; AORTA MEDIA; ARTICLE; BIOCOMPATIBILITY; CALCIFICATION; CARDIOVASCULAR INFLAMMATION; CELL ADHESION; CELL FUNCTION; CELL HYPERPLASIA; CELL INVASION; CELL POPULATION; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVITY; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMPLANTATION; IN VIVO STUDY; MALE; MYOFIBROBLAST; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SURFACE PROPERTY; SYSTEMIC CIRCULATION; THICKNESS; THROMBOSIS; ZYMOGRAPHY; ANIMAL; AORTA VALVE; BIOPROSTHESIS; CHEMISTRY; CYTOLOGY; METHODOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TISSUE ENGINEERING; WISTAR RAT; PROCEDURES;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; AORTIC VALVE; BIOPROSTHESIS; CELL ADHESION; FIBRONECTINS; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; TISSUE ENGINEERING;

EID: 84878530398     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.04.037     Document Type: Article

References (29)

1. O'Brien M.F., Stafford E.G., Gardner M.A., Pohlner P.G., Tesar P.J., Cochrane A.D., et al. Allograft aortic valve replacement (long-term follow-up). Ann Thorac Surg 1995, 60:S65-S70.
2. Clarke D.R., Campbell D.N., Hayward A.R., Bishop D.A. Degeneration of aortic valve allografts in young recipients. JThorac Cardiovasc Surg 1993, 105:934-941.
3. Green M.K., Walsh M.D., Dare A., Hogan P.G., Zhao X.M., Frazer I.H., et al. Histologic and immunohistochemical responses after aortic valve allografts in the rat. Ann Thorac Surg 1998, 66:S216-S220.
4. Shaddy R.E., Hunter D.D., Osborn K.A., Lambert L.M., Minich L.L., Hawkins J.A., et al. Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. Circulation 1996, 94:1063-1067.
5. Grauss R.W., Hazekamp M.G., van Vliet S., Gittenberger-de Groot A.C., DeRuiter M.C. Decellularization of rat aortic valve allografts reduces leaflet destruction and extracellular matrix remodeling. JThorac Cardiovasc Surg 2003, 126:2003-2010.
6. Lichtenberg A., Tudorache I., Cebotari S., Suprunov M., Tudorache G., Goerler H., et al. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions. Circulation 2006, 114:I559-I565.
7. Akhyari P., Kamiya H., Gwanmesia P., Aubin H., Tschierschke R., Hoffmann S., et al. Invivo functional performance and structural maturation of decellularised allogenic aortic valves in the subcoronary position. Eur J Cardiothorac Surg 2010, 38:539-546.
8. Cebotari S., Lichtenberg A., Tudorache I., Hilfiker A., Mertsching H., Leyh R., et al. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 2006, 114:I132-I137.
9. da Costa F.D., Costa A.C., Prestes R., Domanski A.C., Balbi E.M., Ferreira A.D., et al. The early and midterm function of decellularized aortic valve allografts. Ann Thorac Surg 2010, 90:1854-1860.
10. Kasimir M.T., Rieder E., Seebacher G., Nigisch A., Dekan B., Wolner E., et al. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. JHeart Valve Dis 2006, 15:278-286.
11. Meyer S.R., Chiu B., Churchill T.A., Zhu L., Lakey J.R., Ross D.B. Comparison of aortic valve allograft decellularization techniques in the rat. JBiomed Mater Res A 2006, 79:254-262.
12. Zhou J., Fritze O., Schleicher M., Wendel H.P., Schenke-Layland K., Harasztosi C., et al. Impact of heart valve decellularization on 3-D ultrastructure, immunogenicity and thrombogenicity. Biomaterials 2010, 31:2549-2554.
13. Rieder E., Seebacher G., Kasimir M.T., Eichmair E., Winter B., Dekan B., et al. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 2005, 111:2792-2797.
14. Shimada T., Nishibe T., Miura H., Hazama K., Kato H., Kudo F., et al. Improved healing of small-caliber, long-fibril expanded polytetrafluoroethylene vascular grafts by covalent bonding of fibronectin. Surg Today 2004, 34:1025-1030.
15. Zhou M., Liu Z., Wei Z., Liu C., Qiao T., Ran F., et al. Development and validation of small-diameter vascular tissue from a decellularized scaffold coated with heparin and vascular endothelial growth factor. Artif Organs 2009, 33:230-239.
16. Assmann A., Akhyari P., Delfs C., Flögel U., Jacoby C., Kamiya H., et al. Development of a growing rat model for the invivo assessment of engineered aortic conduits. JSurg Res 2012, 176:367-375.
17. Joghetaei N., Akhyari P., Rauch B.H., Cullen P., Lichtenberg A., Rudelius M., et al. Extracellular matrix metalloproteinase inducer (CD147) and membrane type 1-matrix metalloproteinase are expressed on tissue macrophages in calcific aortic stenosis and induce transmigration in an artificial valve model. JThorac Cardiovasc Surg 2011, 142:191-198.
18. Ramalanjaona G.R., Kempczinski R.F., Ogle J.D., Silberstein E.B. Fibronectin coating of an experimental PTFE vascular prosthesis. JSurg Res 1986, 41:479-483.
19. Budd J.S., Allen K.E., Bell P.R., James R.F. The effect of varying fibronectin concentration on the attachment of endothelial cells to polytetrafluoroethylene vascular grafts. JVasc Surg 1990, 12:126-130.
20. Baguneid M., Murray D., Salacinski H.J., Fuller B., Hamilton G., Walker M., et al. Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes. Biotechnol Appl Biochem 2004, 39:151-157.
21. Gwanmesia P., Ziegler H., Eurich R., Barth M., Kamiya H., Karck M., et al. Opposite effects of transforming growth factor-β1 and vascular endothelial growth factor on the degeneration of aortic valvular interstitial cell are modified by the extracellular matrix protein fibronectin: implications for heart valve engineering. Tissue Eng Part A 2010, 16:3737-3746.
22. Griese D.P., Ehsan A., Melo L.G., Kong D., Zhang L., Mann M.J., et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003, 108:2710-2715.
23. Assmann A., Benim A.C., Gül F., Lux P., Akhyari P., Boeken U., et al. Pulsatile extracorporeal circulation during on-pump cardiac surgery enhances aortic wall shear stress. JBiomech 2012, 45:156-163.
24. de Valence S., Tille J.C., Mugnai D., Mrowczynski W., Gurny R., Möller M., et al. Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model. Biomaterials 2012, 33:38-47.
25. Meyer S.R., Nagendran J., Desai L.S., Rayat G.R., Churchill T.A., Anderson C.C., et al. Decellularization reduces the immune response to aortic valve allografts in the rat. JThorac Cardiovasc Surg 2005, 130:469-476.
26. Numata S., Fujisato T., Niwaya K., Ishibashi-Ueda H., Nakatani T., Kitamura S. Immunological and histological evaluation of decellularized allograft in a pig model: comparison with cryopreserved allograft. JHeart Valve Dis 2004, 13:984-990.
27. Shi Y., O'Brien J.E., Fard A., Mannion J.D., Wang D., Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996, 94:1655-1664.
28. Yang G., Li H., Tang G., Wu L., Zhao K., Cao Q., et al. Increased neointimal formation in cystathionine gamma-lyase deficient mice: role of hydrogen sulfide in α5β1-integrin and matrix metalloproteinase-2 expression in smooth muscle cells. JMol Cell Cardiol 2012, 52:677-688.
29. Cha M.C., Purslow P.P. The activities of MMP-9 and total gelatinase respond differently to substrate coating and cyclic mechanical stretching in fibroblasts and myoblasts. Cell Biol Int 2010, 34:587-591.